EBSCO Information Services’ (EBSCO) Clinical Decisions has announced the introduction of Dyna AI, a generative artificial intelligence (AI) capability designed to deliver critical information to clinicians faster than ever before. Dyna AI is now available for Dynamic Health™ and DynaMedex®, providing industry-leading, trusted evidence-based, expert-curated responses to support clinical decision-making.
The healthcare environment demands that clinicians have quick access to high-quality information to make informed decisions at the point of care. Leveraging the meticulously curated resources of DynaMedex and Dynamic Health, Dyna AI uses a retrieval augmented generation framework to present concise, actionable, and reliable answers to clinical questions. This innovation aims to redefine clinical decision support by enhancing the speed and accuracy with which clinicians can access essential information.
The information provided by Dyna AI adheres to EBSCO Clinical Decisions’ Principles for the Responsible Use of AI, which emphasize Quality, Security and Patient Privacy, Transparency, Governance, and Equity. These principles ensure that the use of AI in clinical settings maintains the highest standards of accuracy, security, and ethical responsibility.
The introduction of Dyna AI aligns with EBSCO’s commitment to supporting clinicians with the best tools and resources to enhance patient care. By integrating AI capabilities into their clinical decision support systems, EBSCO aims to streamline the process of accessing vital medical information, ultimately improving patient outcomes.
Click here to read the original press release.
More News in this Theme
